Comparison Between the Internal and External Pressure Filtration Method of Cell-Free and Concentrated Ascites Reinfusion Therapy Using the Same Cancerous Ascites.


Journal

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
ISSN: 1744-9987
Titre abrégé: Ther Apher Dial
Pays: Australia
ID NLM: 101181252

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 27 12 2018
accepted: 28 01 2019
pubmed: 27 4 2019
medline: 7 1 2020
entrez: 27 4 2019
Statut: ppublish

Résumé

Cell-free and concentrated ascites reinfusion therapy (CART) by internal filtration pressure method (internal method) and external filtration pressure method (external method) using the same cancerous ascites was performed. The rate of rise in circuit pressure and recovered components were compared between the two methods. The factors related to circuit pressure rise were also researched. In both methods, circuit pressure rose in 50% of cases. The recovery rates of IgG, IgA, IgM, and haptoglobin were significantly higher for the internal method than for the external method, whereas the recovery rate of α

Identifiants

pubmed: 31025830
doi: 10.1111/1744-9987.12821
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

237-241

Informations de copyright

© 2019 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.

Auteurs

Sachie Yamada (S)

Blood Purification Center, Fujita Health University Hospital, Toyoake, Japan.

Midori Hasegawa (M)

Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.

Norio Nii (N)

Blood Purification Center, Fujita Health University Hospital, Toyoake, Japan.

Masao Kato (M)

Blood Purification Center, Fujita Health University Hospital, Toyoake, Japan.

Atsushi Ohashi (A)

Faculty of Clinical Engineering, Fujita Health University School of Health Sciences, Toyoake, Japan.

Ryota Suzuki (R)

Medical Product Development Headquarters, Asahi Kasei Medical Co., Ltd., Tokyo, Japan.

Masakazu Komatsu (M)

Medical Product Development Headquarters, Asahi Kasei Medical Co., Ltd., Tokyo, Japan.

Kosei Abe (K)

Blood Purification Technology Development Department, Asahi Kasei Medical MT Corporation, Nobeoka, Japan.

Yosuke Hata (Y)

Blood Purification Technology Development Department, Asahi Kasei Medical MT Corporation, Nobeoka, Japan.

Kazuo Takahashi (K)

Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.

Hiroki Hayashi (H)

Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.

Shigehisa Koide (S)

Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.

Naotake Tsuboi (N)

Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.

Daijo Inaguma (D)

Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.

Yukio Yuzawa (Y)

Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH